New Key Statistics Module, Z-Score and F-Score
SZSE:300534 Key Ratios
Market Cap ¥ M | 2,165.88 |
Enterprise Value ¥ M | 1,924.82 |
P/E(ttm) | 42.50 |
PE Ratio without NRI | 42.25 |
Forward PE Ratio | -- |
Price/Book | 3.34 |
Price/Sales | 2.08 |
Price/Free Cash Flow | 13.27 |
Price/Owner Earnings | 255.00 |
Payout Ratio % | 0.12 |
Revenue (TTM) ¥ M | 1,039.00 |
EPS (TTM) ¥ | 0.17 |
Beneish M-Score | -3.6 |
10-y EBITDA Growth Rate % | -4.10 |
5-y EBITDA Growth Rate % | 30.20 |
y-y EBITDA Growth Rate % | -2.00 |
EV-to-EBIT | 18.72 |
EV-to-EBITDA | 18.72 |
PEG | 1.40 |
Shares Outstanding M | 303.35 |
Net Margin (%) | 4.90 |
Operating Margin % | 9.26 |
Pre-tax Margin (%) | 9.50 |
Quick Ratio | 1.12 |
Current Ratio | 1.32 |
ROA % (ttm) | 3.76 |
ROE % (ttm) | 8.06 |
ROIC % (ttm) | 10.00 |
Dividend Yield % | 0.28 |
Altman Z-Score | 3.41 |
SZSE:300534 Number of Guru Trades
SZSE:300534 Volume of Guru Trades
Gurus Latest Trades with SZSE:300534
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300534 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Insider Transactions
No Available Data